Search all trials

Find therapies in clinical trials near you – page 17

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Interstitial lung disease

Not recruiting

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Spain

Participants:65+ years
Substances:Bi 1015550

Contact Research Centre

Non-small cell lung cancer recurrent+1

Not recruiting

InvestigationalNo placebo

Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cln-081

Contact Research Centre

Neoplasm

Not recruiting

InvestigationalNo placebo

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Omx-0407

Contact Research Centre

Gastrooesophageal reflux disease+1

Not recruiting

Registered drugNo placebo

Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Almagate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Erlotinib and LY2875358 for Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Mutations After Initial Erlotinib Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Emibetuzumab

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study of SCO-101 with FOLFIRI for Patients with Metastatic Colorectal Cancer Resistant to FOLFIRI

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Disodium Folinate

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Ovarian cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Multiple sclerosis+2

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Find therapies in clinical trials near you – page 17

296 trials match your criteria

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Non-small cell lung cancer recurrent+1

Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

Neoplasm

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

Gastrooesophageal reflux disease+1

Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

Non-small cell lung cancer

Study of Erlotinib and LY2875358 for Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Mutations After Initial Erlotinib Treatment

Colorectal cancer metastatic

Study of SCO-101 with FOLFIRI for Patients with Metastatic Colorectal Cancer Resistant to FOLFIRI

Primary progressive multiple sclerosis

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Non-small cell lung cancer metastatic

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Neoplasm

Study of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors

Ovarian cancer+1

Study Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer

Multiple sclerosis+1

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Multiple sclerosis+2

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.